Skip to main content
Subscribe
  • Sign Up Free
  • Login
  • Subscribe
  • News
    • Current News
    • Providers
    • Insurance
    • Government
    • Finance
    • Technology
    • Safety & Quality
    • Digital Health
    • Transformation
    • ESG
    • People
    • Regional News
    • Digital Edition (Web Version)
    • Patients
    • Operations
    • Care Delivery
    • Payment
    • Midwest
    • Northeast
    • South
    • West
  • Blogs
    • AI
    • Deals
    • Layoff Tracker
    • HIMSS 2023
  • Opinion
    • Breaking Bias
    • Commentaries
    • Letters
    • From the Editor
  • Events & Awards
    • Awards
    • Conferences
    • Galas
    • Virtual Briefings
    • Webinars
    • Nominate/Eligibility
    • 100 Most Influential People
    • 50 Most Influential Clinical Executives
    • Best Places to Work in Healthcare
    • Excellence in Governance
    • Health Care Hall of Fame
    • Healthcare Marketing Impact Awards
    • Top 25 Emerging Leaders
    • Top Innovators
    • Diversity in Healthcare
      • - Luminaries
      • - Top 25 Diversity Leaders
      • - Leaders to Watch
    • Women in Healthcare
      • - Luminaries
      • - Top 25 Women Leaders
      • - Women to Watch
    • Digital Health Transformation Summit
    • ESG: The Implementation Imperative Summit
    • Leadership Symposium
    • Social Determinants of Health Symposium
    • Women Leaders in Healthcare Conference
    • Best Places to Work Awards Gala
    • Health Care Hall of Fame Gala
    • Top 25 Diversity Leaders Gala
    • Top 25 Women Leaders Gala
    • - Hospital of the Future
    • - Value Based Care
    • - Hospital at Home
    • - Workplace of the Future
    • - AI and Digital Health
    • - Future of Staffing
    • - Hospital of the Future (Fall)
  • Multimedia
    • Podcast - Beyond the Byline
    • Sponsored Podcast - Healthcare Insider
    • Sponsored Video Series - One on One
    • Sponsored Video Series - Checking In with Dan Peres
  • Data & Insights
    • Data & Insights Home
    • Hospital Financials
    • Staffing & Compensation
    • Quality & Safety
    • Mergers & Acquisitions
    • Data Archive
    • Resource Guide: By the Numbers
    • Surveys
    • Data Points
  • Newsletters
  • MORE+
    • Contact Us
    • Advertise
    • Media Kit
    • Jobs
    • People on the Move
    • Reprints & Licensing
MENU
Breadcrumb
  1. Home
  2. Technology
January 13, 2015 11:00 PM

IOM urges vast changes in clinical trial data sharing

Sabriya Rice
  • Tweet
  • Share
  • Share
  • Email
  • More
    Reprints Print

    The Institute of Medicine on Wednesday released four recommendations to address practices that often have left relevant medical research unpublished and useful data unattainable by independent researchers. The guidelines could represent a sea change in how the research enterprise is thinking about its responsibilities, say advocacy groups, ethicists and academic researchers.

    The recommendations outline major changes to how results of medical studies are handled in the United States, including timetables for the sharing of adverse event summaries and analyzable data sets.

    “The issue is no longer whether to share clinical trial data, but what specific data to share, at what time, and under what conditions,” wrote Dr. Bernard Lo, chair of the IOM committee on strategies for responsible sharing of clinical trial data, in his preface. The guidelines represent an attempt to balance the interests of stakeholders with the public demand for information on the effectiveness and safety of therapies, he said.

    The first recommendation is that data sharing should be the expectation and the norm. Stakeholders in clinical trials are asked to foster a culture which promotes the development of a data sharing infrastructure, require data sharing plans as part of their protocol, and detail during the informed consent process what data will be available to participants during and after participation in a trial.

    The second recommendation is for the full analyzable set of data from a given study to be available no later than 18 months after the study completion, with exceptions for trials intended to support regulatory application. The full data on newly approved products or drugs should be made available within 30 days of regulatory approval.

    The next recommendation calls for the implementation of strategies to encourage data sharing, including the creation of technological platforms, boosting financial support, and creating incentives.

    The fourth recommendation calls on sponsors of the study to take the lead on making all the recommendations happen.

    While critics of past practices see the recommendations as a major change of tone, they still have concerns about whether they will translate into actual practice.

    The guidelines would be a major step in the right direction, if they are implemented, but there is a major emphasis on the 'if ', said Dr. Michael Carome, director of the Health Research Group for Public Citizen. “Many times we have seen recommendations sit in a book on a shelf and never get implemented. That is all too common,” he said.

    That concern was shared by Diane Zuckerman, president of the National Center for Health Research, a nonprofit research and advocacy organization. She also points to wording in the IOM report which would allow the exclusion of information that is considered confidential commercial information. “Like most proposals, the devil is in the details,” she says. "Based on the track record of companies and government regulators, essential information that no reasonable person would think is a trade secret is often redacted as trade secrets.”

    “Based on the track record of companies and government regulators, essential information that no reasonable person would think is a trade secret is often redacted as trade secrets,” she says.

    The IOM 249-page report acknowledges there are many challenges and considerations in tackling the complex issues, but that all stakeholders, from drug and device manufactures, to medical journals and regulatory bodies, have the responsibility to the public and to the voluntary participants in the trials.

    “Although there are technical hurdles, we need to change how we think about data,” wrote Dr. Jeffrey Drazen, editor-in-chief of the New England Journal of Medicine and IOM committee member, in an editorial published Wednesday. “We need to view it as a community resource, much like a shared park, rather than as personal property.”

    The IOM study was supported by the National Academy of Sciences, National Institutes of Health, Food and Drug Administration, as well as several drug and device manufacturers, including AbbVie, GlaxoSmithKline, Bayer, Pfizer Inc and Sanofi-Aventis, among others, many of whom already have been voluntarily seeking out collaborative efforts to share data over the past few years.

    For example, in 2013 GlaxoSmithKline launched its data-sharing website clinicalstudydatarequest.com, which includes participation from Boehringer Ingelheim, Roche, Sanofi and ViiV Healthcare.

    The website alltrials.net—launched last year in Europe by a group including BMJ, Cochrane the Dartmouth Institute for Health Policy & Clinical Practice— has requested that all past and present trials be registered and their results be reported.

    Last January, Johnson & Johnson entered an agreement to share clinical trial data through the Yale School of Medicine's Open Data Access Project, which will serve as an independent body to review requests from investigators and physicians seeking access. Wednesday, that group announced that is it making available all clinical trial data for medical devices and diagnostics for Johnson & Johnson.

    Follow Sabriya Rice on Twitter: @Sabriyarice

    Letter
    to the
    Editor

    Send us a letter

    Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

    Recommended for You
    doctor_patient_tablet_getty_i_i.jpg
    How AI may influence pain medication prescriptions
    Amir Dan Rubin
    Amazon's One Medical CEO to step down later this year
    Most Popular
    1
    Centene to lay off 2,000 workers
    2
    How health systems are battling price-gouging allegations
    3
    Senate advances bill to temporarily aid hospitals, health centers
    4
    Elevance, Blue Cross Louisiana halt $2.5B proposed deal
    5
    Tower Health to sell urgent care centers, close others
    Sponsored Content
    Digital Health Intelligence Newsletter: Sign up to receive a twice-weekly (T, F) morning newsletter featuring the latest reporting on technologies, trends, players and money fueling the rapid changes in how healthcare is developed, paid for and delivered.
    Get Newsletters

    Sign up for enewsletters and alerts to receive breaking news and in-depth coverage of healthcare events and trends, as they happen, right to your inbox.

    Subscribe Today
    MH Magazine Cover

    MH magazine offers content that sheds light on healthcare leaders’ complex choices and touch points—from strategy, governance, leadership development and finance to operations, clinical care, and marketing.

    Subscribe
    Connect with Us
    • LinkedIn
    • Twitter
    • Facebook
    • RSS

    Our Mission

    Modern Healthcare empowers industry leaders to succeed by providing unbiased reporting of the news, insights, analysis and data.

    Contact Us

    (877) 812-1581

    Email us

     

    Resources
    • Contact Us
    • Help Center
    • Advertise with Us
    • Ad Choices
    • Sitemap
    Editorial Dept
    • Submission Guidelines
    • Code of Ethics
    • Awards
    • About Us
    Legal
    • Terms and Conditions
    • Privacy Policy
    • Privacy Request
    Modern Healthcare
    Copyright © 1996-2023. Crain Communications, Inc. All Rights Reserved.
    • News
      • Current News
      • Providers
      • Insurance
      • Government
      • Finance
      • Technology
      • Safety & Quality
      • Digital Health
      • Transformation
        • Patients
        • Operations
        • Care Delivery
        • Payment
      • ESG
      • People
      • Regional News
        • Midwest
        • Northeast
        • South
        • West
      • Digital Edition (Web Version)
    • Blogs
      • AI
      • Deals
      • Layoff Tracker
      • HIMSS 2023
    • Opinion
      • Breaking Bias
      • Commentaries
      • Letters
      • From the Editor
    • Events & Awards
      • Awards
        • Nominate/Eligibility
        • 100 Most Influential People
        • 50 Most Influential Clinical Executives
        • Best Places to Work in Healthcare
        • Excellence in Governance
        • Health Care Hall of Fame
        • Healthcare Marketing Impact Awards
        • Top 25 Emerging Leaders
        • Top Innovators
        • Diversity in Healthcare
          • - Luminaries
          • - Top 25 Diversity Leaders
          • - Leaders to Watch
        • Women in Healthcare
          • - Luminaries
          • - Top 25 Women Leaders
          • - Women to Watch
      • Conferences
        • Digital Health Transformation Summit
        • ESG: The Implementation Imperative Summit
        • Leadership Symposium
        • Social Determinants of Health Symposium
        • Women Leaders in Healthcare Conference
      • Galas
        • Best Places to Work Awards Gala
        • Health Care Hall of Fame Gala
        • Top 25 Diversity Leaders Gala
        • Top 25 Women Leaders Gala
      • Virtual Briefings
        • - Hospital of the Future
        • - Value Based Care
        • - Hospital at Home
        • - Workplace of the Future
        • - AI and Digital Health
        • - Future of Staffing
        • - Hospital of the Future (Fall)
      • Webinars
    • Multimedia
      • Podcast - Beyond the Byline
      • Sponsored Podcast - Healthcare Insider
      • Sponsored Video Series - One on One
      • Sponsored Video Series - Checking In with Dan Peres
    • Data & Insights
      • Data & Insights Home
      • Hospital Financials
      • Staffing & Compensation
      • Quality & Safety
      • Mergers & Acquisitions
      • Data Archive
      • Resource Guide: By the Numbers
      • Surveys
      • Data Points
    • Newsletters
    • MORE+
      • Contact Us
      • Advertise
      • Media Kit
      • Jobs
      • People on the Move
      • Reprints & Licensing